Alzheimer's disease - challenges for the future / / edited by Inga Zerr.

There is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description,...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:[Place of publication not identified] : : IntechOpen,, [2015]
©2015
Year of Publication:2015
Language:English
Physical Description:1 online resource (372 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545902404498
ctrlnum (CKB)4970000000098898
(NjHacI)994970000000098898
(oapen)https://directory.doabooks.org/handle/20.500.12854/66707
(EXLCZ)994970000000098898
collection bib_alma
record_format marc
spelling Zerr, Inga edt
Alzheimer's disease - challenges for the future / edited by Inga Zerr.
Alzheimer's disease
Alzheimer's Disease – Challenges for the Future
IntechOpen 2015
[Place of publication not identified] : IntechOpen, [2015]
©2015
1 online resource (372 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on print version record.
Open access Unrestricted online access star
There is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description, major factors which trigger pathology are still unknown. The role of comorbidity is discussed controversially. Important environmental risk factors in AD development are continuous stress, low education and cardiovascular risk factors such as alcohol intake, smoking, hypertension. The role of lipids and cholesterol has been recognized, but the relevant pathogenetic steps are still to be identified. There is an urgent need to understand molecular disease pathogenesis in order to develop early therapeutic targets for the disease.
English
Alzheimer's disease.
Neurology & clinical neurophysiology
953-51-2137-5
Zerr, Inga, editor.
language English
format eBook
author2 Zerr, Inga,
author_facet Zerr, Inga,
author2_variant i z iz
i z iz
author2_role TeilnehmendeR
title Alzheimer's disease - challenges for the future /
spellingShingle Alzheimer's disease - challenges for the future /
title_full Alzheimer's disease - challenges for the future / edited by Inga Zerr.
title_fullStr Alzheimer's disease - challenges for the future / edited by Inga Zerr.
title_full_unstemmed Alzheimer's disease - challenges for the future / edited by Inga Zerr.
title_auth Alzheimer's disease - challenges for the future /
title_alt Alzheimer's disease
Alzheimer's Disease – Challenges for the Future
title_new Alzheimer's disease - challenges for the future /
title_sort alzheimer's disease - challenges for the future /
publisher IntechOpen
IntechOpen,
publishDate 2015
physical 1 online resource (372 pages)
isbn 953-51-7242-5
953-51-2137-5
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC523
callnumber-sort RC 3523 A494 42015
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.831
dewey-sort 3616.831
dewey-raw 616.831
dewey-search 616.831
work_keys_str_mv AT zerringa alzheimersdiseasechallengesforthefuture
AT zerringa alzheimersdisease
AT zerringa alzheimersdiseaseachallengesforthefuture
status_str n
ids_txt_mv (CKB)4970000000098898
(NjHacI)994970000000098898
(oapen)https://directory.doabooks.org/handle/20.500.12854/66707
(EXLCZ)994970000000098898
carrierType_str_mv cr
is_hierarchy_title Alzheimer's disease - challenges for the future /
author2_original_writing_str_mv noLinkedField
_version_ 1787548726649159680
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02217nam a2200421 i 4500</leader><controlfield tag="001">993545902404498</controlfield><controlfield tag="005">20231108172645.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr#|||||||||||</controlfield><controlfield tag="008">221006s2015 xx o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7242-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000098898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000098898</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66707</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000098898</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC523</subfield><subfield code="b">.A494 2015</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.831</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zerr, Inga</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Alzheimer's disease - challenges for the future /</subfield><subfield code="c">edited by Inga Zerr.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Alzheimer's disease</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Alzheimer's Disease – Challenges for the Future</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2015</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Place of publication not identified] :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (372 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on print version record.</subfield></datafield><datafield tag="506" ind1=" " ind2=" "><subfield code="a">Open access</subfield><subfield code="f">Unrestricted online access</subfield><subfield code="2">star</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">There is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description, major factors which trigger pathology are still unknown. The role of comorbidity is discussed controversially. Important environmental risk factors in AD development are continuous stress, low education and cardiovascular risk factors such as alcohol intake, smoking, hypertension. The role of lipids and cholesterol has been recognized, but the relevant pathogenetic steps are still to be identified. There is an urgent need to understand molecular disease pathogenesis in order to develop early therapeutic targets for the disease.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Alzheimer's disease.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Neurology &amp; clinical neurophysiology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-2137-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zerr, Inga,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-11-09 11:42:51 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338043240004498&amp;Force_direct=true</subfield><subfield code="Z">5338043240004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338043240004498</subfield></datafield></record></collection>